To our knowledge, CA IX is not currently used for therapy in nuclear medicine but was used for molecular imaging of glioblastoma and could be used in the near future for phenotypic imaging and theranostic approach (Li et al., 2015). This evidence concerns the gene CA9 and glioblastoma.